Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-27 6:17 pm Sale |
2024-11-18 | 13D | Syros Pharmaceuticals, Inc. SYRS |
Samsara BioCapital, L.P. | 707,114 2.600% |
-1,808,409 (-71.89%) |
Filing History |
| 2025-03-25 7:40 pm Purchase |
2025-03-18 | 13D | AlloVir, Inc. ALVR |
Samsara BioCapital, L.P. | 11,448,081 61.200% |
11,448,081 (New Position) |
Filing History |
| 2025-03-17 9:06 pm Purchase |
2025-03-13 | 13D | Mineralys Therapeutics, Inc. MLYS |
Samsara BioCapital, L.P. | 5,736,305 9.100% |
644,278 (+12.65%) |
Filing History |
| 2025-02-14 5:54 pm Sale |
2024-12-31 | 13G | IO Biotech, Inc. IOBT |
Samsara BioCapital, L.P. | 2,631,578 3.800% |
-1,008,437 (-27.70%) |
Filing History |
| 2024-12-20 4:59 pm Purchase |
2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA |
Samsara BioCapital, L.P. | 679,486 6.100% |
679,486 (New Position) |
Filing History |
| 2024-11-27 4:25 pm Purchase |
2024-11-25 | 13G | Neurogene Inc. NGNE |
Samsara BioCapital, L.P. | 1,717,127 11.600% |
434,564 (+33.88%) |
Filing History |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA |
Samsara BioCapital, L.P. | 3,281,766 4.980% |
501,505 (+18.04%) |
Filing History |
| 2024-11-14 5:45 pm Purchase |
2024-09-30 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
Samsara BioCapital, L.P. | 4,415,689 9.600% |
294,000 (+7.13%) |
Filing History |
| 2024-11-04 4:15 pm Purchase |
2024-10-28 | 13G | Septerna, Inc. SEPN |
Samsara BioCapital, L.P. | 2,768,520 6.200% |
2,768,520 (New Position) |
Filing History |
| 2024-10-11 4:15 pm Purchase |
2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR |
Samsara BioCapital, L.P. | 824,155 6.500% |
824,155 (New Position) |
Filing History |
| 2024-10-07 8:59 pm Sale |
2024-10-07 | 13D | Scholar Rock Holding Corporation SRRK |
Samsara BioCapital, L.P. | 6,757,255 8.300% |
-1,121,047 (-14.23%) |
Filing History |
| 2024-08-27 4:20 pm Purchase |
2024-07-01 | 13D | Alumis Inc. Common Stock ALMS |
Samsara BioCapital, L.P. | 3,266,498 6.900% |
3,266,498 (New Position) |
Filing |
| 2024-04-25 8:39 pm Purchase |
2024-04-15 | 13G | Leap Therapeutics, Inc. LPTX |
Samsara BioCapital, L.P. | 2,442,352 6.400% |
2,442,352 (New Position) |
Filing History |
| 2024-03-29 4:06 pm Purchase |
2024-03-27 | 13D | Nkarta, Inc. NKTX |
Samsara BioCapital, L.P. | 3,768,035 5.400% |
900,000 (+31.38%) |
Filing History |
| 2024-03-25 8:42 pm Purchase |
2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ |
Samsara BioCapital, L.P. | 1,213,865 4.800% |
1,213,865 (New Position) |
Filing History |
| 2024-03-05 7:52 pm Purchase |
2024-02-27 | 13D | vTv Therapeutics Inc. VTVT |
Samsara BioCapital, L.P. | 265,620 10.400% |
265,620 (New Position) |
Filing History |
| 2024-02-14 4:19 pm Sale |
2023-12-31 | 13G | Rain Enhancement Technologies Holdco Inc RAIN |
Samsara BioCapital, L.P. | 0 0.000% |
-2,260,652 (Position Closed) |
Filing History |
| 2024-02-14 4:16 pm Purchase |
2023-12-18 | 13G | Neurogene Inc. NGNE |
Samsara BioCapital, L.P. | 1,282,563 9.990% |
1,282,563 (New Position) |
Filing History |
| 2024-02-12 4:48 pm Purchase |
2024-02-12 | 13D | Mineralys Therapeutics, Inc. MLYS |
Samsara BioCapital, L.P. | 5,092,027 10.300% |
5,092,027 (New Position) |
Filing History |
| 2023-12-26 5:19 pm Purchase |
2023-12-21 | 13D | Syros Pharmaceuticals, Inc. SYRS |
Samsara BioCapital, L.P. | 2,515,523 9.500% |
909,977 (+56.68%) |
Filing History |